3,207
Views
3
CrossRef citations to date
0
Altmetric
Brief Report

An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors

ORCID Icon, , , , , , , , , , , & ORCID Icon show all
Article: 2163838 | Received 04 Oct 2022, Accepted 27 Dec 2022, Published online: 19 Jan 2023

References

  • Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–20. doi:10.1038/nri2515.
  • Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7(2):99–109. doi:10.1038/nrmicro2070.
  • Ananthakrishnan AN, Higuchi LM, Huang ES, Khalili H, Richter JM, Fuchs CS, Chan AT, Higuchi LM, Huang ES, Khalili H, et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med. 2012;156(5):350–359. doi:10.7326/0003-4819-156-5-201203060-00007.
  • Klein A, Eliakim R. Non steroidal anti-inflammatory drugs and inflammatory bowel disease. Pharmaceuticals. 2010;3(4):1084–1092. doi:10.3390/ph3041084.
  • Moninuola OO, Milligan W, Lochhead P, Khalili H. Systematic review with meta-analysis: association between Acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn’s disease and ulcerative colitis exacerbation. Aliment Pharmacol Ther. 2018;47(11):1428–1439. doi:10.1111/apt.14606.
  • Wang X, Tang Q, Hou H, Zhang W, Li M, Chen D, Gu Y, Wang B, Hou J, Liu Y, et al. Gut microbiota in NSAID enteropathy: new insights from inside. Front Cell Infect Microbiol. 2021;11:679396. doi:10.3389/fcimb.2021.679396.
  • Robert A, Asano T. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins. 1977;14(2):333–341. doi:10.1016/0090-6980(77)90178-2.
  • Rogers MAM, Aronoff DM. The influence of non-steroidal anti-inflammatory drugs on the gut microbiome. Clin Microbiol Infect. 2016;22(2):178 e171–178 e179. doi:10.1016/j.cmi.2015.10.003.
  • Lázár B, B LS, Hutka B, S TA, Mohammadzadeh A, Berekméri E, Ágg B, Balogh M, Sajtos V, Király K. A comprehensive time course and correlation analysis of indomethacin-induced inflammation, bile acid alterations and dysbiosis in the rat small intestine. Biochem Pharmacol. 2021;190:114590. doi:10.1016/j.bcp.2021.114590.
  • Mortensen B, Murphy C, O’Grady J, Lucey M, Elsafi G, Barry L, Westphal V, Wellejus A, Lukjancenko O, C EA, et al. Bifidobacteriumbreve bif195 protects against small-intestinal damage caused by acetylsalicylic acid in healthy volunteers. Gastroenterology. 2019;157(3):637–646 e634. doi:10.1053/j.gastro.2019.05.008.
  • Chow J, Tang H, Mazmanian SK. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr Opin Immunol. 2011;23(4):473–480. doi:10.1016/j.coi.2011.07.010.
  • Nadalian B, Yadegar A, Houri H, Olfatifar M, Shahrokh S, Asadzadeh Aghdaei H, Suzuki H, Zali MR. Prevalence of the pathobiont adherent-invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2021;36(4):852–863. doi:10.1111/jgh.15260.
  • Palmela C, Chevarin C, Xu Z, Torres J, Sevrin G, Hirten R, Barnich N, Ng SC, Colombel JF. Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut. 2018;67(3):574–587. doi:10.1136/gutjnl-2017-314903.
  • Small CL, Reid-Yu SA, McPhee JB, Coombes BK. Persistent infection with Crohn’s disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat Commun. 2013;4(1):1957. doi:10.1038/ncomms2957.
  • Buisson A, Sokol H, Hammoudi N, Nancey S, Treton X, Nachury M, Fumery M, Hebuterne X, Rodrigues M, P HJ, et al. Role of adherent and invasive Escherichia coli in Crohn’s disease: lessons from the postoperative recurrence model. Gut. 2022;gutjnl-2021–325971. doi:10.1136/gutjnl-2021-325971.
  • Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407–420. doi:10.1038/nri.2016.58.
  • Aguilera M, Darby T, Melgar S. The complex role of inflammasomes in the pathogenesis of Inflammatory Bowel Diseases - lessons learned from experimental models. Cytokine Growth Factor Rev. 2014;25(6):715–730. doi:10.1016/j.cytogfr.2014.04.003.
  • De la Fuente M, Franchi L, Araya D, Diaz-Jimenez D, Olivares M, Alvarez-Lobos M, Golenbock D, J GM, Lopez-Kostner F, Quera R, et al. Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int J Med Microbiol. 2014;304(3–4):384–392. doi:10.1016/j.ijmm.2014.01.002.
  • Mao L, Kitani A, Similuk M, J OA, Albenberg L, Kelsen J, Aktay A, Quezado M, Yao M, Montgomery-Recht K, et al. Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn’s disease. J Clin Invest. 2018;128(5):1793–1806. doi:10.1172/JCI98642.
  • Higashimori A, Watanabe T, Nadatani Y, Takeda S, Otani K, Tanigawa T, Yamagami H, Shiba M, Tominaga K, Fujiwara Y, et al. Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy. Mucosal Immunol. 2016;9(3):659–668. doi:10.1038/mi.2015.89.
  • Di Sabatino A, Ciccocioppo R, Luinetti O, Ricevuti L, Morera R, Cifone MG, Solcia E, Corazza GR. Increased enterocyte apoptosis in inflamed areas of Crohn’s disease. Dis Colon Rectum. 2003;46(11):1498–1507. doi:10.1007/s10350-004-6802-z.
  • Newton K, Dixit VM, Kayagaki N. Dying cells fan the flames of inflammation. Science. 2021;374(6571):1076–1080. doi:10.1126/science.abi5934.
  • S LA, F FH, Marquardt B, E MB, Magg T, Li Y, Liu Y, Ghalandary M, Lammens K, Hollizeck S, et al. Intestinal inflammation and dysregulated immunity in patients with inherited caspase-8 deficiency. Gastroenterology. 2019;156(1):275–278. doi:10.1053/j.gastro.2018.09.041.
  • Gunther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H, J WM, M HS, Tenzer S, F NM, et al. Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature. 2011;477(7364):335–339. doi:10.1038/nature10400.
  • Mashimo M, Onishi M, Uno A, Tanimichi A, Nobeyama A, Mori M, Yamada S, Negi S, N BX, R KJ, et al. The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis. J Biol Chem. 2021;296. doi:10.1074/jbc.RA120.014479.
  • Gram AM, Booty LM, Bryant CE. Chopping GSDMD: caspase-8 has joined the team of pyroptosis-mediating caspases. Embo J. 2019;38(10):e102065. doi:10.15252/embj.2019102065.
  • Sarhan J, C LB, I MH, Li P, Nilson R, Y TA, Rongvaux A, C BS, Shao F, R GD, et al. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection. Proc Natl Acad Sci USA. 2018;115(46):E10888–E10897. doi:10.1073/pnas.1809548115.
  • Kang S, Fernandes-Alnemri T, Rogers C, Mayes L, Wang Y, Dillon C, Roback L, Kaiser W, Oberst A, Sagara J, et al. Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat Commun. 2015;6(1):7515. doi:10.1038/ncomms8515.
  • Chi W, Li F, Chen H, Wang Y, Zhu Y, Yang X, Zhu J, Wu F, Ouyang H, Ge J, et al. Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1beta production in acute glaucoma. Proc Natl Acad Sci USA. 2014;111(30):11181–11186. doi:10.1073/pnas.1402819111.
  • Antonopoulos C, Russo HM, El Sanadi C, Martin BN, Li X, Kaiser WJ, Mocarski ES, Dubyak GR. Caspase-8 as an effector and regulator of NLRP3 inflammasome signaling. J Biol Chem. 2015;290(33):20167–20184. doi:10.1074/jbc.M115.652321.
  • Chung H, Vilaysane A, Lau A, Stahl M, Morampudi V, Bondzi-Simpson A, M PJ, A BN, C FM, L BP, et al. NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis. Cell Death Differ. 2016;23(8):1331–1346. doi:10.1038/cdd.2016.14.
  • Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM. Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer. Gastroenterology. 2004;127:80–93. doi:10.1053/j.gastro.2004.03.054.
  • Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, Hogardt M, Pfeffer K, Russmann H, Hardt WD. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun. 2003;71(5):2839–2858. doi:10.1128/IAI.71.5.2839-2858.2003.
  • Melgar S, Karlsson A, Michaëlsson E, Di Sabatino A, Ciccocioppo R, Luinetti O, Ricevuti L, Morera R, Cifone MG, Solcia E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol. 2005;288(6):G1328–G1338. doi:10.1152/ajpgi.00467.2004.
  • D GA, Heger K, F SA, Reja R, Yan D, C PV, Suto E, Zhang J, C KY, C FE, et al. Integration of innate immune signalling by caspase-8 cleavage of N4BP1. Nature. 2020;587(7833):275–280. doi:10.1038/s41586-020-2796-5.
  • Kim SY, Hwangbo H, Lee H, Park C, Kim GY, Moon SK, Yun SJ, Kim WJ, Cheong J, Choi YH. Induction of apoptosis by coptisine in Hep3B hepatocellular carcinoma cells through activation of the ROS-mediated JNK signaling pathway. Int J Mol Sci. 2020;21(5502). doi:10.3390/ijms21155502.
  • Gkouskou KK, Deligianni C, Tsatsanis C, Eliopoulos AG. The gut microbiota in mouse models of inflammatory bowel disease. Front Cell Infect Microbiol. 2014;4:28. doi:10.3389/fcimb.2014.00028.
  • Xiao L, Zheng H, Li J, Zeng M, He D, Liang J, Sun K, Luo Y, Li F, Ping B, et al. Targeting NLRP3 inflammasome modulates gut microbiota, attenuates corticospinal tract injury and ameliorates neurobehavioral deficits after intracerebral hemorrhage in mice. Biomed Pharmacother. 2022;149:112797. doi:10.1016/j.biopha.2022.112797.
  • M SE, V GL, L R-GF, De Meis J, M PR, Wu Z, C C-ST, H SS, G LU, M SR, et al. Caspase-8 activity prevents type 2 cytokine responses and is required for protective T cell-mediated immunity against Trypanosoma cruzi infection. J Immunol. 2005;174(10):6314–6321. doi:10.4049/jimmunol.174.10.6314.
  • Shawki A, McCole DF. Mechanisms of intestinal epithelial barrier dysfunction by adherent-invasive Escherichia coli. Cell Mol Gastroenterol Hepatol. 2017;3(1):41–50. doi:10.1016/j.jcmgh.2016.10.004.
  • Holgersen K, Kvist PH, Markholst H, Hansen AK, Holm TL. Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse–a model mimicking inflammatory bowel disease. J Crohns Colitis. 2014;8(2):147–160. doi:10.1016/j.crohns.2013.08.002.
  • Itani S, Watanabe T, Nadatani Y, Sugimura N, Shimada S, Takeda S, Otani K, Hosomi S, Nagami Y, Tanaka F, et al. NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis. Sci Rep. 2016;6:39075. doi:10.1038/srep39075.
  • Perera AP, Fernando R, Shinde T, Gundamaraju R, Southam B, Sohal SS, Robertson AAB, Schroder K, Kunde D, Eri R. MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice. Sci Rep. 2018;8(1):8618. doi:10.1038/s41598-018-26775-w.
  • Zhang J, Fu S, Sun S, Li Z, Guo B. Inflammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol. 2014;7(5):1139–1150. doi:10.1038/mi.2014.1.
  • Lu J, Xie S, Deng Y, Xie X, Liu Y. Blocking the NLRP3 inflammasome reduces osteogenic calcification and M1 macrophage polarization in a mouse model of calcified aortic valve stenosis. Atherosclerosis. 2022;347:28–38. doi:10.1016/j.atherosclerosis.2022.03.005.
  • Kim CH, Park J, Kim M. Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation. Immune Netw. 2014;14(6):277–288. doi:10.4110/in.2014.14.6.277.
  • Takeshita K, Mizuno S, Mikami Y, Sujino T, Saigusa K, Matsuoka K, Naganuma M, Sato T, Takada T, Tsuji H, et al. A single species of clostridium subcluster xiva decreased in ulcerative colitis patients. Inflamm Bowel Dis. 2016;22(12):2802–2810. doi:10.1097/MIB.0000000000000972.
  • Xu L, Zhang C, He D, Jiang N, Bai Y, Xin Y. Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis. Life Sci. 2020;253:117747. doi:10.1016/j.lfs.2020.117747.
  • Somchit M, Faizah S, Zuraini A, Khairi H, Hasiah A, Zakaria Z. Selective in vitro cytotoxic effects of piroxicam and mefenamic acid on several cancer cells lines. Res J Pharmacol. 2009;3:15–18.
  • Wadolkowski EA, Laux DC, Cohen PS. Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus. Infect Immun. 1988;56(5):1030–1035. doi:10.1128/iai.56.5.1030-1035.1988.
  • Spees AM, Wangdi T, Lopez CA, Kingsbury DD, Xavier MN, Winter SE, Tsolis RM, J BA. Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration. MBio. 2013;4(4):e00430–00413. doi:10.1128/mBio.00430-13.
  • Hall LJ, Murphy CT, Hurley G, Quinlan A, Shanahan F, Nally K, Melgar S. Natural killer cells protect against mucosal and systemic infection with the enteric pathogen Citrobacter rodentium. Infect Immun. 2013;81(2):460–469. doi:10.1128/IAI.00953-12.
  • Las Heras V, G CA, J RF, Cabrera-Rubio R, G CP, M HC, Pinheiro J, K RJ, Melgar S, D CP, et al. Short-term consumption of a high-fat diet increases host susceptibility to Listeria monocytogenes infection. Microbiome. 2019;7(1):7. doi:10.1186/s40168-019-0621-x.
  • Saiz-Gonzalo G, Hanrahan N, Rossini V, Singh R, Ahern M, Kelleher M, Hill S, O’Sullivan R, Fanning A, T WP, et al. Regulation of CEACAM family members by IBD-associated triggers in intestinal epithelial cells, their correlation to inflammation and relevance to IBD pathogenesis. Front Immunol. 2021;12:655960. doi:10.3389/fimmu.2021.655960.
  • Hall LJ, Faivre E, Quinlan A, Shanahan F, Nally K, Melgar S. Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis. Dig Dis Sci. 2011;56(1):79–89. doi:10.1007/s10620-010-1240-3.
  • J RF, M AA, S FR, J L-ME, M PE, G CA, W OK, J MP, Iwai S, Crits-Christoph A, et al. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease. Nat Commun. 2020;11(1):1512. doi:10.1038/s41467-020-15342-5.
  • Grenié M, Denelle P, Tucker CM, Munoz F, Violle C. Funrar: an R package to characterize functional rarity. Divers Distrib. 2017;23(12):1365–1371. doi:10.1111/ddi.12629.
  • Wickham H. Reshaping data with the reshape package. J Stat Softw. 2007;21(12):1–20. doi:10.18637/jss.v021.i12.
  • Wickham H. ggplot2: elegant graphics for data analysis. New York: springer; 2016.
  • Kassambara A. Package ‘ggpubr’. R Package Version. 2019. https://cran.r-project.org/web/packages/ggpubr/index.html.
  • Oksanen J, Blanchet FG, Kindt R, Legendre P, Minchin P, O’hara R, Simpson G, Solymos P, Stevens MHH, Wagner H. Community ecology package. R Package Version. 2013;2:321–326.
  • McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013;8(4):e61217. doi:10.1371/journal.pone.0061217.
  • Wright K. pals: color palettes, colormaps, and tools to evaluate them. R Package Version. 2019;1. https://cran.r-project.org/web/packages/pals/index.html.
  • Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8.
  • Team R C. R: a language and environment for statistical computing (version 3.5.2. Vienna (Austria): R Foundation for Statistical Computing; 2018.
  • Wei T, Simko V, Levy M, Xie Y, Jin Y, Zemla J. Package ‘corrplot’. Statistician. 2017;56:e24.
  • Aguilera M, Rossini V, Hickey A, Simnica D, Grady F, D FV, Moloney A, Pawley L, Fanning A, McCarthy L, et al. Inflammasome signaling regulates the microbial-neuroimmune axis and visceral pain in mice. Int J Mol Sci. 2021;22(15):8336. doi:10.3390/ijms22158336.
  • Singh R, Rossini V, Stockdale SR, Saiz-Gonzalo G, Hanrahan N, D’Souza T, Clooney A, Draper LA, Hill C, Nally K. An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors. 2022. doi:10.1101/2022.08.18.504384.